BioTuesdays

Category - Markets

Aurinia Logo

HCW ups Aurinia price target to $25

H.C. Wainwright raised its price target for Aurinia Pharmaceuticals (NASDAQ:AUPH) to $25 from $15 after assessing the value of the company’s recently-received new dosing regimen patent. The stock closed at $6.49 on May...